Intelligence-led Assessment of Pharmaceuticals in the Environment (iPiE)

Active pharmaceutical ingredients (APIs) of medicines for human use can be released to the environment during the manufacturing process, following use by patients or when unused medicines are disposed of in an incorrect manner. As APIs are biologically active compounds, concerns have been raised about the potential effects of APIs in the environment on human […]

Novel processing routes for effective sewage sludge management (ROUTES)

The ROUTES project aimed to evaluate new routes of sewage sludge treatment and management matching the needs of different wastewater origins and different digested sludge utilisations. Elimination of micropollutants was targeted for agricultural sludge application, and minimising the production volume for other sludge disposal routes. Research of ECT in sludge-soil interactions focussed on three aspects: […]

Ecological function and biodiversity indicators in European soils (EcoFINDERS)

The strategic goal of EcoFINDERS is to provide the EC with tools to design and implement strategies for ensuring sustainable use of soils, including: (1) the characterisation of the biodiversity of European soils, (2) the determination of relations between soil biodiversity, soil functions and ecosystem services, and (3) the design of policy-relevant and cost-effective indicators […]

Communicating environmental impacts on water quality, availability and use (ComEnvir)

The project aims to narrow the gap between environmental research focusing on water (resources, water quality, pollution and biodiversity issues) sponsored by the European Union (EU) and European citizens. The project will communicate results and activities of environmental research with two specific target groups: teachers and students as primary target group, and the general public […]

Optimized strategies for risk assessment of industrial chemicals through integration of non-test and test information (OSIRIS)

OSIRIS (Optimized Strategies for Risk Assessment of Chemicals based on Intelligent Testing) develops integrated testing strategies (ITS) which can be used for the European Union regulation REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals) to significantly increase the use of non-testing information for risk assessment of industrial chemicals and regulatory decision making. This includes alternative […]

Cause-effect relations of key pollutants on the European rivers biodiversity (KEYBIOEFFECTS)

The overall objective of the research and training network KEYBIOEFFECTS was to provide young scientists with the skills and knowledge needed to assess the effects of pollution (with specific focus on key pollutants) on the biodiversity of European rivers and to transfer this knowledge to different stakeholder groups. Recognizing the importance of understanding cause-effect relationships […]

Models for assessing and forecasting the impact of environmental key pollutants on marine and freshwater ecosystems and biodiversity (MODELKEY)

The Water Framework Directive of the European Union requires a good ecological status of the European water bodies by 2015. One of the driving forces for an insufficient ecological status and reduced biodiversity of freshwater and marine ecosystems is chemical stress due to environmental pollutants. The project MODELKEY aims to contribute to the assessment, understanding […]

Novel methods for integrated risk assessment of cumulative stressors in Europe (NoMiracle)

NoMiracle (Novel Methods for Integrated Risk Assessment of CumuLative stressors in Europe) supports the development and improvement of methodologies, which describe and help to understand combined stressor effects to human health and the environment. In particular, the project studies the transfer of pollutants between different environmental compartments, including how these processes are influenced by natural […]

Environmental risk assessment of pharmaceuticals (ERAPharm)

The widespread detection of a large variety of pharmaceuticals in the environment has raised concern about the potential impact of these bioactive substances on the environment. The overall aim of ERAPharm was to advance existing knowledge and methods for the environmental risk assessment of pharmaceuticals. Within the three years of the project, the impact of […]